Skip to main content
Premium Trial:

Request an Annual Quote

CIDR to Expand Illumina Services to Include Whole-Genome Association Research

NEW YORK, Feb. 15 (GenomeWeb News) - Illumina said today that the Center for Inherited Disease Research will offer investigators a new genome-wide association service based on its Sentrix HumanHap300 BeadChip and Infinium assay.

 

CIDR is already using Illumina's Array Matrix and GoldenGate assay for SNP linkage and custom genotyping, Illumina said.

 

The new service will be integrated into CIDR's existing Illumina BeadLab system, which the company said features production-scale sample processing and will use its existing lab information management system, according to Illumina.

 

Financial details were not discussed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.